Regeneron Pharmaceuticals
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for Regeneron Pharmaceuticals OPTION, CUSIP 99AA2VGAK.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for Regeneron Pharmaceuticals OPTION, CUSIP 99AA2VGAK.